Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.10.24	Abbott Laboratories Boosts FY24 Earnings Outlook - Update (RTTNews)
16.10.24	Abbott Laboratories Q3 Profit Increases, Beats Estimates (RTTNews)
07.08.24	Medtronic Announces FDA Approval Of Simplera CGM; Partners With Abbott To Expand CGM Options (RTTNews)
18.07.24	Abbott Laboratories Boosts FY24 Earnings Outlook - Update (RTTNews)
18.07.24	Abbott Laboratories Q2 Profit Decreases, But Beats Estimates (RTTNews)
10.06.24	Abbott's Lingo, Libre Rio OTC Continuous Glucose Monitoring Systems Gets FDA Clearance (RTTNews)
29.04.24	Abbott's Dissolving Stent For People With Chronic Limb-Threatening Ischemia Gets FDA Nod (RTTNews)
17.04.24	Abbott Laboratories Reports Fall In Q1 Bottom Line (RTTNews)
02.04.24	Abbott Says FDA Approves First-of-Its-Kind TriClip Transcatheter Edge-to-edge Repair System (RTTNews)
01.04.24	Abbott: I-STAT TBI Cartridge Receives FDA Clearance To Be Used With Whole Blood (RTTNews)
06.03.24	Abbott: FreeStyle Libre Systems, GLP-1 Medicines Together Is Beneficial For Type 2 Diabetes Patients (RTTNews)
14.02.24	FDA Panel Votes In Favor Of Abbott's TriClip System To Treat Leaky Tricuspid Heart Valve (RTTNews)
31.01.24	Abbott Launches New Protality Brand High-protein Nutrition Shake (RTTNews)
24.01.24	Abbott Laboratories Guides FY24 Adj. EPS In Line With Estimates - Update (RTTNews)
24.01.24	Abbott Laboratories Q4 Profit Increases, Inline With Estimates (RTTNews)
18.12.23	Abbott to Present at J.P. Morgan Healthcare Conference (PR Newswire)
15.12.23	Abbott Increases Quarterly Dividend for 52nd Consecutive Year (PR Newswire)
13.11.23	Abbott Says Aspirin-free Medication Regimen Benefits People With HeartMate 3 Heart Pump (RTTNews)
13.11.23	Late-Breaking Data Show an Aspirin-Free Medication Regimen Benefits People with Abbott's HeartMate 3™ Heart Pump (PR Newswire)
08.11.23	Participants in Abbott's Food as Medicine Program Showed Clinically Significant Improvements in Managing Diabetes (PR Newswire)
02.11.23	Abbott Obtains FDA Approval For HPV Test To Run On Alinity M (RTTNews)
02.11.23	Abbott Receives FDA Approval for HPV Test to Run on Alinity m, Offering Primary HPV Screening and Assessment of High-Risk Cancer-Causing Types of HPV (PR Newswire)
01.11.23	Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology (PR Newswire)
31.10.23	Abbott and Damar Hamlin Team Up to Build Heart Health Community with New HeartMates Program (PR Newswire)
26.10.23	Ninety-One Percent of Young Adults With Student Loans Say Financial Stress is Impacting Their Wellness -- Abbott Launches Blueprint of Award-Winning Program to Help Companies Tackle This Problem (PR Newswire)
25.10.23	Late-Breaking Data Show Esprit™ BTK Drug-Eluting Resorbable Scaffold Reduces Chronic Limb-Threatening Ischemia Progression Compared to the Standard of Care (PR Newswire)
25.10.23	FDA Approves New Therapy For Rare Blood Cancers (RTTNews)
25.10.23	Abbott : Data Showcase Benefits Of Minimally Invasive Devices For People With Leaky Heart Valves (RTTNews)
25.10.23	Late-Breaking Data Showcase the Benefits of Abbott's Minimally Invasive Devices for People With Leaky Heart Valves (PR Newswire)
18.10.23	Abbott Laboratories Lifts Midpoint Of FY23 Earnings Outlook Range - Update (RTTNews)
18.10.23	Abbott Laboratories Q3 Profit Beats Estimates (RTTNews)
27.09.23	Abbott Hosts Conference Call for Third-Quarter Earnings (PR Newswire)
22.09.23	Abbott Completes Acquisition of Bigfoot Biomedical (PR Newswire)
21.09.23	Abbott Declares 399th Consecutive Quarterly Dividend (PR Newswire)
20.09.23	Abbott Inks Deal With MAbxience To Commercialize Biosimilar Molecules In Emerging Markets (RTTNews)
20.09.23	Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets (PR Newswire)
19.09.23	Abbott and WeightWatchers Connected App Experience is Now Available for People Living with Diabetes (PR Newswire)
05.09.23	Abbott To Buy Bigfoot Biomedical (RTTNews)
05.09.23	Abbott to Acquire Bigfoot Biomedical, Furthering Efforts to Develop Personalized, Connected Solutions for People with Diabetes (PR Newswire)
20.07.23	Abbott Laboratories Reaffirms FY23 Adj. EPS Outlook - Update (RTTNews)
20.07.23	Abbott Laboratories Q2 Profit Decreases, but beats estimates (RTTNews)
05.07.23	Abbott's Minimally Invasive Dual Chamber Leadless Pacemaker System Gets FDA Approval (RTTNews)
05.07.23	Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker (PR Newswire)
29.06.23	Abbott Hosts Conference Call for Second-Quarter Earnings (PR Newswire)
22.06.23	Abbott's FreeStyle Libre® 2 Receives National Reimbursement in France for All People with Diabetes Who Use Insulin¹ (PR Newswire)
09.06.23	Abbott Declares 398th Consecutive Quarterly Dividend (PR Newswire)
31.05.23	Abbott, Real Madrid and the Real Madrid Foundation Band Together to 'Beat Malnutrition' Globally Through New Campaign (PR Newswire)
24.05.23	Abbott: MONITOR-HF Trial With CardioMEMS Sensor Meets Primary Endpoint (RTTNews)
24.05.23	European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations (PR Newswire)
20.05.23	Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten
19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Abbott Laboratories

Aktien Top/Flop

Abbott Laboratories Peer Group Nachrichten

Meistgelesene Nachrichten